{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T15:11:59Z","timestamp":1788793919855,"version":"build-2803163510"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Hospital"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Idiopathic normal pressure hydrocephalus (iNPH) is a treatable condition, but predicting shunt response remains challenging. Cerebrospinal fluid (CSF) biomarkers, including phosphorylated tau (p-tau181), have been suggested as potential predictors, although existing evidence is inconsistent.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      In this retrospective single-center study, we included 230 patients with probable or possible iNPH who underwent shunt surgery and had available CSF biomarker data for Amyloid beta42, total tau and phosphorylated tau 181. Patients were divided into two cohorts based on assay method (Innotest\n                      <jats:sup>\u00ae<\/jats:sup>\n                      and Elecsys\n                      <jats:sup>\u00ae<\/jats:sup>\n                      ). The primary outcome was improvement in gait score. Secondary outcomes included cognition, continence, and overall clinical response. Predictive performance of CSF p-tau181 was evaluated using logistic regression and receiver operating characteristic (ROC) analyses.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Mean CSF p-tau181 levels did not differ significantly between responders and non-responders in either cohort. In multivariable logistic regression analyses adjusted for age and sex, CSF p-tau181 was not associated with shunt response (Innotest\n                      <jats:sup>\u00ae<\/jats:sup>\n                      : OR 0.997 (0.972\u20131.024),\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.815; Elecsys\n                      <jats:sup>\u00ae<\/jats:sup>\n                      : OR 1.091 (0.910\u20131.419),\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.429). Findings were consistent across two CSF p-tau181 assay platforms, although the Elecsys\n                      <jats:sup>\u00ae<\/jats:sup>\n                      cohort was underpowered for calculating AUC with only 14 non-responders. Similar results were observed across secondary outcomes and after exclusion of patients with high CSF p-tau181 levels to reduce potential confounding by concomitant Alzheimer\u2019s disease pathology.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>CSF p-tau181 does not demonstrate clinically meaningful predictive value for shunt response in patients with iNPH and cannot alone guide patient selection for shunt surgery. Future research should focus on multimodal approaches integrating clinical, radiological, and biochemical markers.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10072-026-09357-x","type":"journal-article","created":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T02:06:21Z","timestamp":1788746781000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association between p-tau181 in cerebrospinal fluid and shunt response in patients with normal-pressure hydrocephalus"],"prefix":"10.1007","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1706-8568","authenticated-orcid":false,"given":"Amon","family":"Bergner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6442-2910","authenticated-orcid":false,"given":"Christian Sand\u00f8e","family":"Musaeus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5461-162X","authenticated-orcid":false,"given":"Anja Hviid","family":"Simonsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5938-000X","authenticated-orcid":false,"given":"Tina N\u00f8rgaard","family":"Munch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6724-7281","authenticated-orcid":false,"given":"Jonathan Frederik","family":"Carlsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4750-4911","authenticated-orcid":false,"given":"Steen Gregers","family":"Hasselbalch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,7]]},"reference":[{"key":"9357_CR1","doi-asserted-by":"publisher","DOI":"10.1111\/cns.13526","author":"Z Wang","year":"2020","unstructured":"Wang Z, Zhang Y, Hu F, Ding J, Wang X (2020) Pathogenesis and pathophysiology of idiopathic normal pressure hydrocephalus. CNS Neurosci Ther. https:\/\/doi.org\/10.1111\/cns.13526","journal-title":"CNS Neurosci Ther"},{"key":"9357_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2018.10.147","author":"K Br\u00e4utigam","year":"2019","unstructured":"Br\u00e4utigam K, Vakis A, Tsitsipanis C (2019) Pathogenesis of idiopathic normal pressure hydrocephalus: a review of knowledge. J Clin Neurosci. https:\/\/doi.org\/10.1016\/j.jocn.2018.10.147","journal-title":"J Clin Neurosci"},{"key":"9357_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2019.11.008","author":"BC Reeves","year":"2020","unstructured":"Reeves BC, Karimy JK, Kundishora AJ, Mestre H, Cerci HM, Matouk C et al (2020) Glymphatic system impairment in Alzheimer\u2019s disease and idiopathic normal pressure hydrocephalus. Trends Mol Med. https:\/\/doi.org\/10.1016\/j.molmed.2019.11.008","journal-title":"Trends Mol Med"},{"key":"9357_CR4","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1056\/NEJM196507152730301","volume":"273","author":"RD Adams","year":"1965","unstructured":"Adams RD, Fisher CM, Hakim S, Ojemann RG, Sweet WH (1965) Symptomatic occult hydrocephalus with normal cerebrospinal-fluid pressure\u2009\u2014\u2009a treatable syndrome. N Engl J Med 273:117\u2013126","journal-title":"N Engl J Med"},{"key":"9357_CR5","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1212\/CON.0000000000000689","volume":"25","author":"NR Graff-Radford","year":"2019","unstructured":"Graff-Radford NR, Jones DT (2019) Normal pressure hydrocephalus. Continuum (Minneap Minn) 25:165\u2013186. https:\/\/doi.org\/10.1212\/CON.0000000000000689","journal-title":"Continuum (Minneap Minn)"},{"key":"9357_CR6","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1148\/96.2.347","volume":"96","author":"M Lemay","year":"1970","unstructured":"Lemay M (1970) New PF 1. radiological diagnosis of occult normal-pressure hydrocephalus. Radiology. 96:347\u201358. https:\/\/doi.org\/10.1148\/96.2.347","journal-title":"Radiology."},{"key":"9357_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/1743-8454-7-18","author":"M Hashimoto","year":"2010","unstructured":"Hashimoto M, Ishikawa M, Mori E, Kuwana N (2010) Diagnosis of idiopathic normal pressure hydrocephalus is supported by MRI-based scheme: a prospective cohort study. Cerebrospinal Fluid Res. https:\/\/doi.org\/10.1186\/1743-8454-7-18","journal-title":"Cerebrospinal Fluid Res"},{"issue":"3","key":"9357_CR8","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/j.1600-0404.2012.01676.x","volume":"126","author":"P Klinge","year":"2012","unstructured":"Klinge P, Hellstr\u00f6m P, Tans J, Wikkels\u00f8 C (2012) One-year outcome in the European multicentre study on iNPH. Acta Neurol Scand 126(3):145\u2013153. https:\/\/doi.org\/10.1111\/j.1600-0404.2012.01676.x","journal-title":"Acta Neurol Scand"},{"key":"9357_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/s00701-013-1835-5","author":"AK Toma","year":"2013","unstructured":"Toma AK, Papadopoulos MC, Stapleton S, Kitchen ND, Watkins LD (2013) Systematic review of the outcome of shunt surgery in idiopathic normal-pressure hydrocephalus. Acta Neurochir. https:\/\/doi.org\/10.1007\/s00701-013-1835-5","journal-title":"Acta Neurochir"},{"issue":"10","key":"9357_CR10","doi-asserted-by":"publisher","first-page":"3047","DOI":"10.1111\/ene.15981","volume":"30","author":"SG Hasselbalch","year":"2023","unstructured":"Hasselbalch SG, Carlsen JF, Alaouie MM, Munch TN, Holst AV, Taudorf S et al (2023) Prediction of shunt response in idiopathic normal pressure hydrocephalus by combined lumbar infusion test and preoperative imaging scoring. Eur J Neurol 30(10):3047\u20133055. https:\/\/doi.org\/10.1111\/ene.15981","journal-title":"Eur J Neurol"},{"issue":"11","key":"9357_CR11","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1136\/jnnp.2007.123620","volume":"79","author":"S Pujari","year":"2008","unstructured":"Pujari S, Kharkar S, Metellus P, Shuck J, Williams MA, Rigamonti D (2008) Normal pressure hydrocephalus: long-term outcome after shunt surgery. J Neurol Neurosurg Psychiatry 79(11):1282\u20131286. https:\/\/doi.org\/10.1136\/jnnp.2007.123620","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"9357_CR12","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1093\/ons\/opy232","volume":"17","author":"A Feletti","year":"2019","unstructured":"Feletti A, D\u2019Avella D, Wikkels\u00f8 C, Klinge P, Hellstr\u00f6m P, Tans J et al (2019) Ventriculoperitoneal shunt complications in the European idiopathic normal pressure hydrocephalus multicenter study. Oper Neurosurg 17(1):97\u2013101. https:\/\/doi.org\/10.1093\/ons\/opy232","journal-title":"Oper Neurosurg"},{"key":"9357_CR13","doi-asserted-by":"publisher","first-page":"687","DOI":"10.3171\/jns.1997.87.5.0687","volume":"87","author":"AJ Boon","year":"1997","unstructured":"Boon AJ, Tans JT, Delwel EJ, Egeler-peerdeman SM, Hanlo PW, Wurzer HA et al (1997) Dutch normal-pressure hydrocephalus study: prediction of outcome after shunting by resistance to outflow of cerebrospinal fluid. J. Neurosurg. 87:687\u2013693","journal-title":"J. Neurosurg."},{"key":"9357_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/s00701-021-04922-z","author":"SG Thavarajasingam","year":"2021","unstructured":"Thavarajasingam SG, El-Khatib M, Rea M, Russo S, Lemcke J, Al-Nusair L et al (2021) Clinical predictors of shunt response in the diagnosis and treatment of idiopathic normal pressure hydrocephalus: a systematic review and meta-analysis. Acta Neurochir. https:\/\/doi.org\/10.1007\/s00701-021-04922-z","journal-title":"Acta Neurochir"},{"key":"9357_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2016.01.028","author":"M Mihalj","year":"2016","unstructured":"Mihalj M, Doli\u0107 K, Koli\u0107 K, Ledenko V (2016) CSF tap test - obsolete or appropriate test for predicting shunt responsiveness? A systemic review. J Neurol Sci. https:\/\/doi.org\/10.1016\/j.jns.2016.01.028","journal-title":"J Neurol Sci"},{"issue":"2","key":"9357_CR16","doi-asserted-by":"publisher","first-page":"223","DOI":"10.3174\/ajnr.A7378","volume":"43","author":"JF Carlsen","year":"2022","unstructured":"Carlsen JF, Backlund ADL, Mardal CA, Taudorf S, Holst AV, Munch TN et al (2022) Can shunt response in patients with idiopathic normal pressure hydrocephalus be predicted from preoperative brain imaging? A retrospective study of the diagnostic use of the normal pressure hydrocephalus radscale in 119 patients. AJNR Am J Neuroradiol 43(2):223\u2013229. https:\/\/doi.org\/10.3174\/ajnr.A7378","journal-title":"AJNR Am J Neuroradiol"},{"key":"9357_CR17","doi-asserted-by":"crossref","unstructured":"Malm J, Graff-Radford NR, Ishikawa M, Kristensen B, Leinonen V, Mori E et al. (2013) Influence of comorbidities in idiopathic normal pressure hydrocephalus-research and clinical care. A report of the ISHCSF task force on comorbidities in INPH [Internet]. Available from: http:\/\/www.fluidsbarrierscns.com\/content\/10\/1\/22","DOI":"10.1186\/2045-8118-10-22"},{"issue":"1","key":"9357_CR18","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2967\/jnmt.125.271788","volume":"54","author":"SL Johnson","year":"2026","unstructured":"Johnson SL (2026) Brain primer, part 2: pathophysiology of neurodegeneration. J Nucl Med Technol 54(1):25\u201331. https:\/\/doi.org\/10.2967\/jnmt.125.271788","journal-title":"J Nucl Med Technol"},{"key":"9357_CR19","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-180816","author":"C Manniche","year":"2019","unstructured":"Manniche C, Hejl AM, Hasselbalch SG, Simonsen AH (2019) Cerebrospinal fluid biomarkers in idiopathic normal pressure hydrocephalus versus Alzheimer\u2019s disease and subcortical ischemic vascular disease: a systematic review. J Alzheimers Dis. https:\/\/doi.org\/10.3233\/JAD-180816","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"9357_CR20","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3233\/JAD-170186","volume":"60","author":"R Santangelo","year":"2017","unstructured":"Santangelo R, Cecchetti G, Bernasconi MP, Cardamone R, Barbieri A, Pinto P et al (2017) Cerebrospinal fluid amyloid-\u03b2 42, total tau and phosphorylated tau are low in patients with normal pressure hydrocephalus: analogies and differences with Alzheimer\u2019s disease. J Alzheimers Dis 60(1):183\u2013200. https:\/\/doi.org\/10.3233\/JAD-170186","journal-title":"J Alzheimers Dis"},{"key":"9357_CR21","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12987-017-0062-5","volume":"14","author":"Z Chen","year":"2017","unstructured":"Chen Z, Liu C, Zhang J, Relkin N, Xing Y, Li Y (2017) Cerebrospinal fluid A\u03b242, t-tau, and p-tau levels in the differential diagnosis of idiopathic normal-pressure hydrocephalus: a systematic review and meta-analysis Fluids and Barriers of the CNS. Fluids Barriers CNS 14:13. https:\/\/doi.org\/10.1186\/s12987-017-0062-5","journal-title":"Fluids Barriers CNS"},{"key":"9357_CR22","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000000916","author":"NR Graff-Radford","year":"2014","unstructured":"Graff-Radford NR (2014) Alzheimer CSF biomarkers may be misleading in normal-pressure hydrocephalus. Neurology. https:\/\/doi.org\/10.1212\/WNL.0000000000000916","journal-title":"Neurology"},{"key":"9357_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/jpm12060935","author":"S Mazzeo","year":"2022","unstructured":"Mazzeo S, Emiliani F, Bagnoli S, Padiglioni S, Del Re LM, Giacomucci G et al (2022) Alzheimer\u2019s disease CSF biomarker profiles in idiopathic normal pressure hydrocephalus. J Pers Med. https:\/\/doi.org\/10.3390\/jpm12060935","journal-title":"J Pers Med"},{"issue":"2","key":"9357_CR24","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1111\/j.1468-1331.2012.03781.x","volume":"20","author":"M Miyajima","year":"2013","unstructured":"Miyajima M, Nakajima M, Ogino I, Miyata H, Motoi Y, Arai H (2013) Soluble amyloid precursor protein \u03b1 in the cerebrospinal fluid as a diagnostic and prognostic biomarker for idiopathic normal pressure hydrocephalus. Eur J Neurol 20(2):236\u2013242. https:\/\/doi.org\/10.1111\/j.1468-1331.2012.03781.x","journal-title":"Eur J Neurol"},{"issue":"1\u20132","key":"9357_CR25","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.jns.2015.07.001","volume":"357","author":"M Nakajima","year":"2015","unstructured":"Nakajima M, Miyajima M, Ogino I, Akiba C, Sugano H, Hara T et al (2015) Cerebrospinal fluid biomarkers for prognosis of long-term cognitive treatment outcomes in patients with idiopathic normal pressure hydrocephalus. J Neurol Sci 357(1\u20132):88\u201395. https:\/\/doi.org\/10.1016\/j.jns.2015.07.001","journal-title":"J Neurol Sci"},{"key":"9357_CR26","doi-asserted-by":"publisher","first-page":"989","DOI":"10.3233\/JAD-180059","volume":"63","author":"C Akiba","year":"2018","unstructured":"Akiba C, Nakajima M, Miyajima M, Ogino I, Motoi Y, Kawamura K et al (2018) Change of amyloid-1-42 toxic conformer ratio after cerebrospinal fluid diversion predicts long-term cognitive outcome in patients with idiopathic normal pressure hydrocephalus. J Alzheimers Dis 63:989\u20131002. https:\/\/doi.org\/10.3233\/JAD-180059","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"9357_CR27","doi-asserted-by":"publisher","first-page":"319","DOI":"10.3233\/JAD-180557","volume":"66","author":"M Nakajima","year":"2018","unstructured":"Nakajima M, Miyajima M, Ogino I, Akib C, Kawamura K, Kamohara C et al (2018) Preoperative phosphorylated tau concentration in the cerebrospinal fluid can predict cognitive function three years after shunt surgery in patients with idiopathic normal pressure hydrocephalus. J Alzheimer\u2019s Dis 66(1):319\u2013331. https:\/\/doi.org\/10.3233\/JAD-180557","journal-title":"J Alzheimer\u2019s Dis"},{"issue":"1","key":"9357_CR28","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1080\/01616412.2020.1831300","volume":"43","author":"K Migliorati","year":"2021","unstructured":"Migliorati K, Panciani PP, Pertichetti M, Borroni B, Archetti S, Rozzini L et al (2021) P-Tau as prognostic marker in long term follow up for patients with shunted iNPH. Neurol Res 43(1):78\u201385. https:\/\/doi.org\/10.1080\/01616412.2020.1831300","journal-title":"Neurol Res"},{"issue":"2","key":"9357_CR29","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1212\/CPJ.0000000000001156","volume":"12","author":"JA Darrow","year":"2022","unstructured":"Darrow JA, Lewis A, Gulyani S, Khingelova K, Rao A, Wang J et al (2022) CSF biomarkers predict gait outcomes in idiopathic normal pressure hydrocephalus. Neurol Clin Pract 12(2):91\u2013101. https:\/\/doi.org\/10.1212\/CPJ.0000000000001156","journal-title":"Neurol Clin Pract"},{"issue":"1","key":"9357_CR30","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12987-022-00309-z","volume":"19","author":"H Lukkarinen","year":"2022","unstructured":"Lukkarinen H, Jeppsson A, Wikkels\u00f6 C, Blennow K, Zetterberg H, Constantinescu R et al (2022) Cerebrospinal fluid biomarkers that reflect clinical symptoms in idiopathic normal pressure hydrocephalus patients. Fluids Barriers CNS. 19(1):11. https:\/\/doi.org\/10.1186\/s12987-022-00309-z","journal-title":"Fluids Barriers CNS."},{"issue":"5","key":"9357_CR31","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/j.1600-0404.2007.00890.x","volume":"116","author":"A \u00c5gren-Wilsson","year":"2007","unstructured":"\u00c5gren-Wilsson A, Lekman A, Sj\u00f6berg W, Rosengren L, Blennow K, Bergenheim AT et al (2007) CSF biomarkers in the evaluation of idiopathic normal pressure hydrocephalus. Acta Neurol Scand 116(5):333\u2013339. https:\/\/doi.org\/10.1111\/j.1600-0404.2007.00890.x","journal-title":"Acta Neurol Scand"},{"key":"9357_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0091974","author":"OT Pyykk\u00f6","year":"2014","unstructured":"Pyykk\u00f6 OT, Lumela M, Rummukainen J, Nerg O, Sepp\u00e4l\u00e4 TT, Herukka SK et al (2014) Cerebrospinal fluid biomarker and brain biopsy findings in idiopathic normal pressure hydrocephalus. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0091974","journal-title":"PLoS ONE"},{"issue":"12","key":"9357_CR33","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.1007\/s00701-016-2980-4","volume":"158","author":"AJ Luikku","year":"2016","unstructured":"Luikku AJ, Hall A, Nerg O, Koivisto AM, Hiltunen M, Helisalmi S et al (2016) Multimodal analysis to predict shunt surgery outcome of 284 patients with suspected idiopathic normal pressure hydrocephalus. Acta Neurochir (Wien) 158(12):2311\u20132319. https:\/\/doi.org\/10.1007\/s00701-016-2980-4","journal-title":"Acta Neurochir (Wien)"},{"key":"9357_CR34","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jns.2018.01.017","volume":"387","author":"YJ Hong","year":"2018","unstructured":"Hong YJ, Kim MJ, Jeong E, Kim JE, Hwang J, Lee JI et al (2018) Preoperative biomarkers in patients with idiopathic normal pressure hydrocephalus showing a favorable shunt surgery outcome. J Neurol Sci 387:21\u201326. https:\/\/doi.org\/10.1016\/j.jns.2018.01.017","journal-title":"J Neurol Sci"},{"issue":"1","key":"9357_CR35","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3171\/2017.7.JNS171005","volume":"130","author":"SA Hamdeh","year":"2019","unstructured":"Hamdeh SA, Virhammar J, Sehlin D, Alafuzoff I, Cesarini KG, Marklund N (2019) Brain tissue A\u03b242 levels are linked to shunt response in idiopathic normal pressure hydrocephalus. J Neurosurg 130(1):121\u2013129. https:\/\/doi.org\/10.3171\/2017.7.JNS171005","journal-title":"J Neurosurg"},{"key":"9357_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10051105","author":"A Vanninen","year":"2021","unstructured":"Vanninen A, Nakajima M, Miyajima M, Rauramaa T, Kokki M, Musialowicz T et al (2021) Elevated CSF LRG and decreased Alzheimer\u2019s disease biomarkers in idiopathic normal pressure hydrocephalus. J Clin Med. https:\/\/doi.org\/10.3390\/jcm10051105","journal-title":"J Clin Med"},{"key":"9357_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s12987-022-00306-2","author":"M Braun","year":"2022","unstructured":"Braun M, Bjurnemark C, Seo W, Freyhult E, Nyholm D, Niemel\u00e4 V et al (2022) Higher levels of neurofilament light chain and total tau in CSF are associated with negative outcome after shunt surgery in patients with normal pressure hydrocephalus. Fluids Barriers CNS. https:\/\/doi.org\/10.1186\/s12987-022-00306-2","journal-title":"Fluids Barriers CNS"},{"issue":"3","key":"9357_CR38","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1177\/13872877251350308","volume":"106","author":"R Gr\u00f8nning","year":"2025","unstructured":"Gr\u00f8nning R, Jeppsson A, Hellstr\u00f6m P, Andr\u00e9n K, Laurell K, Farahmand D et al (2025) Postoperative changes in ventricular cerebrospinal fluid biomarkers with correlation to clinical outcome in idiopathic normal pressure hydrocephalus. J Alzheimers Dis 106(3):1036\u20131048. https:\/\/doi.org\/10.1177\/13872877251350308","journal-title":"J Alzheimers Dis"},{"key":"9357_CR39","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.1227\/01.NEU.0000168185.29659.C5","volume":"57","author":"N Relkin","year":"2005","unstructured":"Relkin N, Marmarou A, Klinge P, Bergsneider M, McL Black P (2005) Diagnosing idiopathic normal-pressure hydrocephalus. Neurosurgery 57:S24-216. https:\/\/doi.org\/10.1227\/01.NEU.0000168185.29659.C5","journal-title":"Neurosurgery"},{"issue":"4","key":"9357_CR40","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/j.1600-0404.2012.01677.x","volume":"126","author":"P Hellstr\u00f6m","year":"2012","unstructured":"Hellstr\u00f6m P, Klinge P, Tans J, Wikkels\u00f8 C (2012) A new scale for assessment of severity and outcome in iNPH. Acta Neurol Scand 126(4):229\u2013237. https:\/\/doi.org\/10.1111\/j.1600-0404.2012.01677.x","journal-title":"Acta Neurol Scand"},{"key":"9357_CR41","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2023-0191","author":"K Dimopoulos","year":"2023","unstructured":"Dimopoulos K, Simonsen AH, Gramkow MH, Schr\u00f8der M, J\u00f8rgensen NR, Rode L et al (2023) Measurement of amyloid-\u03b2 1-42 in cerebrospinal fluid: a comparison of the second generation Elecsys and INNOTEST. Clin Chem Lab Med. https:\/\/doi.org\/10.1515\/cclm-2023-0191","journal-title":"Clin Chem Lab Med"},{"issue":"2","key":"9357_CR42","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1515\/cclm-2022-0516","volume":"61","author":"K Blennow","year":"2023","unstructured":"Blennow K, Stomrud E, Zetterberg H, Borlinghaus N, Corradini V, Manuilova E et al (2023) Second-generation Elecsys cerebrospinal fluid immunoassays aid diagnosis of early Alzheimer\u2019s disease. Clin Chem Lab Med 61(2):234\u2013244. https:\/\/doi.org\/10.1515\/cclm-2022-0516","journal-title":"Clin Chem Lab Med"},{"issue":"22","key":"9357_CR43","doi-asserted-by":"publisher","first-page":"2198","DOI":"10.1056\/nejmoa2503109","volume":"393","author":"MG Luciano","year":"2025","unstructured":"Luciano MG, Williams MA, Hamilton MG, Katzen HL, Dasher NA, Moghekar A et al (2025) A randomized trial of shunting for idiopathic normal-pressure hydrocephalus. N Engl J Med 393(22):2198\u20132209. https:\/\/doi.org\/10.1056\/nejmoa2503109","journal-title":"N Engl J Med"},{"key":"9357_CR44","doi-asserted-by":"crossref","unstructured":"Mori E, Ishikawa M, Kato T, Kazui H, Miyake H, Miyajima M et al. (2012) iNPH Guideline Guidelines for Management of Idiopathic Normal Pressure Hydrocephalus: Second Edition. Neurol Med Chir (Tokyo)","DOI":"10.2176\/nmc.52.775"},{"issue":"147","key":"9357_CR45","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1126\/scitranslmed.3003748","volume":"4","author":"JJ Iliff","year":"2012","unstructured":"Iliff JJ, Wang M, Liao Y, Plogg BA, Peng W, Gundersen GA et al (2012) A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid \u03b2. Sci Transl Med 4(147):147\u2013111. https:\/\/doi.org\/10.1126\/scitranslmed.3003748","journal-title":"Sci Transl Med"},{"key":"9357_CR46","doi-asserted-by":"publisher","DOI":"10.1007\/s00701-022-05154-5","author":"SG Thavarajasingam","year":"2022","unstructured":"Thavarajasingam SG, El-Khatib M, Vemulapalli KV, Iradukunda HAS, Laleye J, Russo S et al (2022) Cerebrospinal fluid and venous biomarkers of shunt-responsive idiopathic normal pressure hydrocephalus: a systematic review and meta-analysis. Acta Neurochir. https:\/\/doi.org\/10.1007\/s00701-022-05154-5","journal-title":"Acta Neurochir"},{"issue":"1","key":"9357_CR47","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1017\/cjn.2017.251","volume":"45","author":"T Pfanner","year":"2018","unstructured":"Pfanner T, Henri-Bhargava A, Borchert S (2018) Cerebrospinal fluid biomarkers as predictors of shunt response in idiopathic normal pressure hydrocephalus: a systematic review. Can J Neurol Sci 45(1):3\u201310. https:\/\/doi.org\/10.1017\/cjn.2017.251","journal-title":"Can J Neurol Sci"},{"key":"9357_CR48","doi-asserted-by":"publisher","DOI":"10.1002\/MDC3.70419","author":"D Campo-Caballero","year":"2025","unstructured":"Campo-Caballero D, Ash E, Fasano A, Martino D, Tullberg M, Alonso Canovas A et al (2025) Clinical and radiological evolution of idiopathic normal pressure hydrocephalus: a critical review. Mov Disord Clin Pract. https:\/\/doi.org\/10.1002\/MDC3.70419","journal-title":"Mov Disord Clin Pract"},{"issue":"2","key":"9357_CR49","doi-asserted-by":"publisher","first-page":"727","DOI":"10.3233\/JAD-230144","volume":"94","author":"A Vanninen","year":"2023","unstructured":"Vanninen A, Lukkarinen H, Kokkola T, Koivisto AM, Kokki M, Musialowicz T et al (2023) Cerebrospinal fluid diagnostics of Alzheimer\u2019s disease in patients with idiopathic normal pressure hydrocephalus. J Alzheimers Dis 94(2):727\u2013736. https:\/\/doi.org\/10.3233\/JAD-230144","journal-title":"J Alzheimers Dis"},{"issue":"7","key":"9357_CR50","doi-asserted-by":"publisher","first-page":"281","DOI":"10.2176\/nmc.oa.2018-0318","volume":"59","author":"T Takeuchi","year":"2019","unstructured":"Takeuchi T, Yajima K (2019) Long-term 4 years follow-up study of 482 patients who underwent shunting for idiopathic normal pressure hydrocephalus -course of symptoms and shunt efficacy rates compared by age group-. Neurol Med Chir (Tokyo) 59(7):281\u2013286. https:\/\/doi.org\/10.2176\/nmc.oa.2018-0318","journal-title":"Neurol Med Chir (Tokyo)"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-026-09357-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-026-09357-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-026-09357-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T15:02:48Z","timestamp":1788793368000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-026-09357-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,7]]},"references-count":50,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["9357"],"URL":"https:\/\/doi.org\/10.1007\/s10072-026-09357-x","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,7]]},"assertion":[{"value":"24 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"According to Danish legislation (VEJ nr 11052 af 02\/07\/1999), the need for explicit written consent was not required since the study was approved as a quality assurance study by the director of the Neuroscience Center, Rigshospitalet (see approval document in supplementary material). Quality assurance studies do not need approval from the ethical committee system in Denmark.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"759"}}